Istradefylline
IUPAC: (E) -1,3- Diethyl -8 -(3,4- dimethoxystyryl ) - 7 -methyl- 3 ,7- dihydro-1H -purine -2 ,6- dione
Psychotropic
Adenosine receptor antagonist
Template: Infobox chemical / molecular formula search available
Istradefyllin is a drug selected from the group of the psychopharmaceuticals which is to be used for the treatment of Parkinson's disease.
- 2.1 Mechanism of action ( pharmacodynamics )
- 3.1 Patent
Clinical information
Areas of application (indications )
Istradefyllin leads to a reduction of the symptom occurring in the conventional treatment of Parkinson's dyskinesia. Currently, the drug is still in clinical trials.
Pharmacological properties
Mechanism of action ( pharmacodynamics )
Istradefyllin is an adenosine A2 receptor antagonist. He thus inhibits the excitatory signal transduction.
Other Information
Patent
- EP 1054012
- WO 9935147
- CA 2315736